Literature DB >> 11172880

The interaction of drug- and psychotherapy in the long-term treatment of depression.

D J Kupfer1, E Frank.   

Abstract

Recent advances in our understanding of both short- and long-term therapeutic interventions for depressive disorders have necessitated greater precision in defining appropriate therapeutic interventions. While these remarkable changes in treatment have been based on the introduction of newer antidepressant agents, the advances have occurred because of more systematic clinical trials and a greater sophistication in defining diagnostic and treatment response criteria. This paper reviews key findings in recurrent depression with respect to long-term treatment. Particular attention is paid to the combination treatment of psychotherapy and antidepressant drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11172880     DOI: 10.1016/s0165-0327(00)00357-8

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  7 in total

Review 1.  Risk for recurrence in depression.

Authors:  Stephanie L Burcusa; William G Iacono
Journal:  Clin Psychol Rev       Date:  2007-03-03

2.  Alzheimer disease: are we intervening too late? Pro.

Authors:  Virginia Olga B Emery
Journal:  J Neural Transm (Vienna)       Date:  2011-06-07       Impact factor: 3.575

3.  Premorbid risk factors for major depressive disorder: are they associated with early onset and recurrent course?

Authors:  Sylia Wilson; Uma Vaidyanathan; Michael B Miller; Matt McGue; William G Iacono
Journal:  Dev Psychopathol       Date:  2014-11

Review 4.  Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment.

Authors:  Alex D H Brown; David A Barton; Gavin W Lambert
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

5.  Current perspectives in the management of treatment-resistant depression.

Authors:  Rajesh M Parikh; Barry D Lebowitz
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

6.  Clinical effectiveness of the electrodermal orienting reactivity test for evaluating relapse and recurrence risk in patients hospitalized for depression.

Authors:  Marta Litwińska-Bołtuć; Łukasz Święcicki; Armin Spreco; Toomas Timpka
Journal:  BMC Psychiatry       Date:  2021-02-10       Impact factor: 3.630

7.  A Web-based screening instrument for depression and anxiety disorders in primary care.

Authors:  Peter Farvolden; Carolina McBride; R Michael Bagby; Paula Ravitz
Journal:  J Med Internet Res       Date:  2003-09-29       Impact factor: 5.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.